Form 4: Veracyte CFO Sells Shares
Insider Transaction (Form 4)
Rebecca Chambers, Chief Financial Officer of Veracyte, Inc., sold 3,652 shares of common stock on September 2, 2026.
Summary
- Tax/exercise-price withholding: disposed of 3,603 Common Stock at $44.88 ($161,703) on September 2, 2026; holds 169,677 after (Direct).
- Open-market sale: disposed of 2,477 Common Stock at $42.81 ($106,030) on September 4, 2026; holds 167,200 after (Direct).
- Open-market sale: disposed of 1,175 Common Stock at $43.71 ($51,364) on September 4, 2026; holds 166,025 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $157,394 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Rebecca Chambers — Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Tax/exercise-price withholding | Common Stock | 3,603 | $45 | $161.7K | 169,677 |
| 2026-09-04 | Open-market sale | Common Stock | 2,477 | $43 | $106.0K | 167,200 |
| 2026-09-04 | Open-market sale | Common Stock | 1,175 | $44 | $51.4K | 166,025 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Tax/exercise-price withholding (3,603 shares) |
| 2026-09-04 | Open-market sale (2,477 shares) |
| 2026-09-04 | Open-market sale (1,175 shares) |
Keywords
insider transaction, Form 4, VCYT, VERACYTE, INC., bearish, Rebecca Chambers
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.